Costimulatory blockade prevents early rejection, promotes lymphocyte apoptosis, and inhibits the upregulation of intragraft interleukin-6 in an orthotopic liver transplant model in the rat

Liver Transplantation

Volumn 8, Issue 5, 2002, Pages 458-468

  Bartlett, Adam S ^a   McCall, John L ^a,b   Ameratunga, Rohan ^c   Howden, Brian ^e   Yeong, Mee Ling ^d   Benjamin, Christopher D ^f   Hess, Donna ^f   Peach, Robert ^g   Munn, Stephen R ^b  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b New Zealand Liver Transplant Unit   (New Zealand)

^c AUCKLAND CITY HOSPITAL   (New Zealand)

^d Diagnostic Medlab ^*  (New Zealand)

^e MONASH UNIVERSITY   (Australia)

^f BIOGEN   (United States)

^g BRISTOL MYERS SQUIBB   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIGEN; ASPARTATE AMINOTRANSFERASE; B7 ANTIGEN; BILIRUBIN; CANCER GROWTH FACTOR; CD4 ANTIGEN; CD40 LIGAND; CD40 LIGAND MONOCLONAL ANTIBODY; CD8 ANTIGEN; CD86 ANTIGEN; CYCLOSPORIN A; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; FAS LIGAND; GAMMA INTERFERON; GRANZYME B; IMMUNOGLOBULIN CLASS; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 7; MESSENGER RNA; PROTEIN BAX; PROTEIN BCL 2; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ALLOGRAFT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CELL DIFFERENTIATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG BLOOD LEVEL; DRUG EFFECT; EFFECTOR CELL; GENE EXPRESSION; GRAFT REJECTION; GRAFT SURVIVAL; HISTOCOMPATIBILITY; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; LIVER TRANSPLANTATION; LYMPHOCYTIC INFILTRATION; MALE; NICK END LABELING; NONHUMAN; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RANDOMIZATION; RAT STRAIN; RECIPIENT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCORING SYSTEM; SURVIVAL TIME; T LYMPHOCYTE ACTIVATION;

EID: 0036097207     PISSN: 15276465     EISSN: None     Source Type: Journal    
DOI: 10.1053/jlts.2002.32979     Document Type: Article

References (56)

1. The role of T-cell costimulatory activation pathways in transplant rejection
2. Prolonged anti-CD40 ligand therapy improves primate allograft cardiac survival
3. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways
4. Treatment with humanised monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates
5. Primary skin allograft acceptance with anti-CD154 in rhesus monkeys
6. Blocking both signal 1 and 2 of T-cell activation prevents apoptosis of alloreactive T cells and induction of peripheral allograft tolerance
7. Blockade of the CD40-CD40 ligand pathway potentiates the capacity of donor-derived dendritic cell progenitors to induce long term cardiac allograft survival
8. Induction of immunological tolerance to islet allografts
9. Adenovirus mediated delivery of CTLA4-Ig can induce tolerance but results in severe graft damage
10. Adenovirus-mediated gene transfer into cold-preserved liver allografts: Survival pattern and unresponsiveness following transduction with CTLA4Ig
11. The importance of the hepatic artery in rat liver transplantation
12. Immunosuppression in vivo by a soluble form of the CTLA4T cell activation molecule
13. Prolonged survival of rat islet and skin xenografts in mice treated with donor spenocytes and anti-CD154 monoclonal antibody
14. A rat small bowel transplant model of chronic rejection: Histopathologic characteristics
15. Tolerance induction by a single donor pretreatment with the adenovirus vector encoding CTLA4Ig gene in rat orthotopic liver transplantation
16. Banff Schema for grading liver allograft rejection: An international consensus document
17. Single step method of RNA isolation by acid guanidinuim thiocyanate-phenol-choloform extraction
18. Expression of Fas (CD95) on human renal tubular epithelial cells
19. Induction of rat liver parenchymal cell apoptosis by hepatic myofibroblasts via transforming growth factor B
20. Apoptosis as a mechanism of cell death in liver allograft rejection
21. Patterns of graft infiltration and cytokine gene expression during the first 10 days of kidney transplantation
22. Mature T lymphocyte apoptosis: Immune regulation in a dynamic and unpredictable antigenic environment
23. CD28 costimulation inhibits TCR-induced apoptosis during a primary T cell response
24. Fas-mediated apoptosis
25. Requirements for T cell apoptosis in the induction of peripheral transplantation tolerance
26. Quantitative detection of immune activation transcripts as a diagnostic tool in kidney transplantation
27. Prevention of islet allograft rejection with engineered myoblasts expressing FasL in mice
28. Apoptosis in the failing human heart
29. CD40-ligand dependant T cell activation: Requirement of B7-CD28 signalling through CD40
30. Immunologic tolerance for immune system-mediated diseases
31. Studies on the interdependence of GP39 and B7 expression and function during antigen-specific immune responses
32. Prolonged acceptance of concordant and discordant xenografts with combined CD40 and CD28 pathway blockade
33. Prevention of chronic rejection in mouse aortic allografts by combined treatment with CTLA4Ig and anti-CD40 ligand monoclonal antibody
34. Suppression of murine allergic contact dermatitis by CTLA4-Ig: Tolerance induction of Th2 responses required additional blockade of CD40-ligand
35. The pathophysiologic roles of interleukin-6 in human disease
36. Correlations and interactions in the production of interleukin-6 (IL-6), IL-1, and tumor necrosis factor (TNF) in human blood mononuclear cells: IL-6 suppresses IL-1 and TNF
37. IL-6 modulates the synthesis of a specific set of acute phase plasma proteins in vivo
38. Recombinant interleukin-6 activates the hypothalamic-pituitary-adrenal axis in humans
39. Clinical significance of interleukin-6 measurement in early rheumatoid arthritis: Relation with laboratory and clinical variables and radiological progression in a three year prospective trial
40. CD40-gp39 interactions play a critical role during allograft rejection
41. Disruption of CD154:CD40 blocks generation of allograft immunity without affecting APC activation
42. Costimulatory function and expression of CD40 ligand, CD80, and CD86 in vasculized murine cardiac allograft rejection
43. Antibody-induced transplant arteriosclerosis is prevented by graft expression of antioxidant and anti-apoptotic genes
44. Lymphokine production in allografts-analysis of RNA by Northern blotting
45. Enhanced expression of CD80(B7-1), CD86(B7-2), and CD40 and their ligands CD28 and CD154 in fulminant hepatic failure
46. CD40 activation induces apoptosis in cultured human hepatocytes via induction of cell surface Fas ligand expression and amplifies Fas mediated hepatocyte death during allograft rejection
47. CD40L expression in human liver allografts during chronic ductopenic rejection
48. CD40 expression on graft infiltrates and parenchymal CD154 (CD40L) induction in human chronic renal allograft rejection
49. Central role of CD40/CD40 ligand (CD154) interactions in transplant rejection
50. CD40 and CD40 ligand are coexpressed on microvessels in vivo in human cardiac allograft rejection
51. Expression of inducible lymphocyte costimulatory molecules in human renal allograft
52. The kinetics of CD154 (CD40L) expression in peripheral blood mononuclear cells of healthy subjects in liver allograft recipients and X-linked hyper-IgM syndrome
53. Differential effects of cyclosporine A, methylprednisolone, mycophenolate and rapamycin on CD154 induction and requirement for NFkB
54. Cyclosporin A inhibits CD40 ligand expression in T lymphocytes
55. The human gp39 promoter
56. CTLA4Ig and anti-CD40 ligand prevent renal allograft rejection in primates